David M. Weber - May 25, 2021 Form 4 Insider Report for ABIOMED INC (ABMD)

Role: Chief Operating Officer
Signature: /s/ Ian W. McLeod (by power of attorney)
Stock symbol: ABMD
Transactions as of: May 25, 2021
Transactions value $: $0
Form type: 4
Date filed: 5/27/2021, 04:55 PM
Previous filing: May 18, 2021
Next filing: Jun 2, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABMD	Common Stock, $.01 par value	Award	$0	+2.69K	+2.17%	$0.00	126K	May 25, 2021	Direct	F4
holding	ABMD	Common Stock, $.01 par value						15.5K	May 25, 2021	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ABMD	Stock Option (Right to Buy)	Award	$0	+4.97K		$0.00	4.97K	May 25, 2021	Common Stock	4.97K	$283.88	Direct	F2, F3
holding	ABMD	Stock Option (Right to Buy)						10.8K	May 25, 2021	Common Stock	0	$21.55	Direct	F1, F2
holding	ABMD	Stock Option (right to buy)						10K	May 25, 2021	Common Stock	0	$66.25	Direct	F1, F2
holding	ABMD	Stock Option (right to buy)						7K	May 25, 2021	Common Stock	0	$99.62	Direct	F2, F3
holding	ABMD	Stock Option (right to buy)						8K	May 25, 2021	Common Stock	0	$134.51	Direct	F2, F3
holding	ABMD	Stock Option (right to buy)						6.5K	May 25, 2021	Common Stock	0	$381.97	Direct	F2, F3
holding	ABMD	Stock Option (Right to Buy)						6K	May 25, 2021	Common Stock	0	$266.39	Direct	F2, F3
holding	ABMD	Stock Option (Right to Buy)						5K	May 25, 2021	Common Stock	0	$223.90	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
F2	These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
F3	Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
F4	Consists of restricted stock units granted to the reporting person. One third of the restricted stock units will vest and the underlying shares will be issued to the reporting person on each of May 25, 2022, May 25, 2023 and May 25, 2024, so long as the reporting person continues to be employed by the issuer on the vesting dates.